Buy Cipla, target Rs 610.0 : Manas Jaiswal

Manas Jaiswal of manasjaiswal.com has a buy call on Cipla Ltd. with a target price of Rs 610.0 . The current market price of Cipla Ltd. is 590.2 Time period given by analyst is Intra Day when Cipla Ltd. price can reach defined target. Manas Jaiswal recommended to keep stoploss at Rs 580
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of ₹ 47484.99 Cr.) operating in Pharmaceuticals and health care sector.

Cipla Ltd. key Products/Revenue Segments include Tablets & Capsules which contributed ₹ 6163.98 Cr to Sales Value (56.16 % of Total Sales), Injections/Sterile Solution which contributed ₹ 1506.33 Cr to Sales Value (13.72 % of Total Sales), Aerosols which contributed ₹ 1276.00 Cr to Sales Value (11.62 % of Total Sales), Bulk Drugs which contributed ₹ 862.17 Cr to Sales Value (7.85 % of Total Sales), Liquids which contributed ₹ 466.89 Cr to Sales Value (4.25 % of Total Sales), Creams which contributed ₹ 307.84 Cr to Sales Value (2.80 % of Total Sales), Export Incentives which contributed ₹ 162.31 Cr to Sales Value (1.47 % of Total Sales), Other Operating Revenue which contributed ₹ 112.22 Cr to Sales Value (1.02 % of Total Sales), Others which contributed ₹ 53.87 Cr to Sales Value (0.49 % of Total Sales), Other Services which contributed ₹ 36.44 Cr to Sales Value (0.33 % of Total Sales) and Scrap which contributed ₹ 26.53 Cr to Sales Value (0.24 % of Total Sales)for the year ending 31-Mar-2017.